跳至主要内容
临床试验/NCT04124185
NCT04124185已完成不适用

Phenotyping and Genotyping Patients With Achromatopsia in Preparation for Gene Therapy Trials

MeiraGTx UK II Ltd1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2011年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
85
试验地点
1
主要终点
Optical Coherence Tomography

研究概览

简要总结

In preparation for human clinical trials we intend to undertake a detailed phenotypic study to help to identify patients who may be suitable for therapeutic intervention. In addition, with the recent availability of advanced imaging modalities, further detailed phenotypic investigations will also be valuable in helping to probe the relationship between structure and function and may shed light on disease mechanisms.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
3 Years 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with molecularly proven Achromatopsia or a typical clinical Achromatopsia phenotype with genetic screening pending.
  • Minimum subject age of 3 years.
  • Able to give consent/parent or guardian able to give consent.

排除标准

  • Patients unable or unwilling to undertake consent or clinical testing.
  • Patients unwilling to donate a blood sample in order to establish the genetic cause of their condition.

结局指标

主要结局

Optical Coherence Tomography

时间窗: 5 years

Corneal curvature

时间窗: 5 years

Axial length

时间窗: 5 years

Contrast sensitivity

时间窗: 5 years

Visual acuity

时间窗: 5 years

Complete ocular examination

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Natural History Study for Achromatopsia | 临床试验